BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · page 3 of 15
The slide highlights a subgroup analysis where the treatment effect becomes statistically significant (p=0.050) in the secondary endpoint.
Conference presentation · before_after · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 5/5
chart 2/2 source-note 1/1 title 2/2
Components 5
bar-grouped bar-grouped source-note action-title headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1